| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 59.58B | 56.15B | 50.13B | 42.98B | 40.77B |
| Gross Profit | 27.54B | 16.17B | 13.84B | 10.83B | 11.33B |
| EBITDA | 10.08B | 12.52B | 10.51B | 7.34B | 10.57B |
| Net Income | 10.31B | 9.27B | 9.03B | 5.25B | 8.53B |
Balance Sheet | |||||
| Total Assets | 247.83B | 246.55B | 230.68B | 199.02B | 200.05B |
| Cash, Cash Equivalents and Short-Term Investments | 2.47B | 39.19B | 33.79B | 25.79B | 97.91B |
| Total Debt | 22.19B | 15.29B | 14.49B | 14.88B | 16.17B |
| Total Liabilities | 168.05B | 178.15B | 166.99B | 148.50B | 140.34B |
| Stockholders Equity | 73.76B | 64.02B | 59.51B | 50.52B | 59.71B |
Cash Flow | |||||
| Free Cash Flow | 14.54B | 16.18B | 12.63B | 11.26B | 11.15B |
| Operating Cash Flow | 14.54B | 16.18B | 12.63B | 11.26B | 11.15B |
| Investing Cash Flow | -12.98B | -13.92B | -7.65B | -5.65B | -6.66B |
| Financing Cash Flow | -1.85B | -2.18B | -4.49B | -5.14B | -4.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $24.97B | 15.63 | 18.88% | 1.88% | 11.08% | 22.01% | |
81 Outperform | $127.74B | 12.00 | 14.69% | 1.22% | 6.68% | -1.78% | |
80 Outperform | $54.64B | 5.29 | 39.47% | 1.91% | 7.07% | 100.42% | |
76 Outperform | $63.80B | 10.34 | 20.58% | 1.49% | 6.75% | 30.83% | |
74 Outperform | $23.96B | 12.95 | 11.85% | ― | -6.96% | -26.28% | |
72 Outperform | $115.34B | 11.81 | 44.53% | 2.20% | 18.35% | 32.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |